Overview

Concentrations of Salmeterol in Blood and Urine

Status:
Unknown status
Trial end date:
2011-03-01
Target enrollment:
0
Participant gender:
Male
Summary
The purpose of the study is to assess the blood and urine concentrations of inhaled salmeterol.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Bispebjerg Hospital
Collaborator:
Hormone Laboratory, Aker University Hospital, Oslo, Norway
Treatments:
Salmeterol Xinafoate
Criteria
Inclusion Criteria:

- Physician-diagnosed asthma with positive reversibility or challenge test.

- Informed consent.

- Age between 18-45 years.

- Sex: male.

- Asthma classified as mild to moderate according to GINA guidelines.

- Used beta-2-agonist in minimum 12 months.

Exclusion Criteria:

- Smokers or ex-smokers with a smoking history of 10 pack years or more.

- Respiratory tract infections within the last 2 weeks prior to study day.

- Subjects with other chronic diseases than asthma and/or allergy.

- Allergy towards the study medicine.

- Use of beta-2-agonist 10 days prior to study day.